Craig Haifer - Concepedia

Author

Craig Haifer

Concord Repatriation General Hospital ORCID

Also Known As

B Baraty, Brandon Baraty, C Haifer, C. Haifer, Craig Haifer

Publications

716

Citations

H-Index

Concepts

All Affiliations

Concord Repatriation General Hospital The University of Sydney UNSW Sydney The University of Melbourne Centre For Digestive Diseases

About

Craig Haifer is an author at Concord Repatriation General Hospital specializing in medicine, transplantation, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	329
2	Hepatology	2	2	47
3	Biology	1	1	39
4	Clinical Immunology	1	1	23
5	Gastroenterology	1	1	243

Craig Haifer

Publications

476

Citations

H-Index

Page 1

	Year	Citations
Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial Craig Haifer, Sudarshan Paramsothy, Nadeem O. Kaakoush, The Lancet. Gastroenterology & hepatology Intestinal TransplantationGastroenterologyTraveler DiarrheaPlacebo-controlled TrialMicrobiology	2021	243
Microbial determinants of effective donors in faecal microbiota transplantation for UC Craig Haifer, Laurence Don Wai Luu, Sudarshan Paramsothy, Gut	2022	50
Gut microbiota strain richness is species specific and affects engraftment Alice Chen-Liaw, Varun Aggarwala, Ilaria Mogno, Nature BiologyMicrobiota StructureMicrobial DiversityDysbiosisMicrobiota	2024	39
Long-Term Bacterial and Fungal Dynamics following Oral Lyophilized Fecal Microbiota Transplantation in Clostridioides difficile Infection Craig Haifer, Sudarshan Paramsothy, Thomas J. Borody, mSystems	2021	30
Targeted individual prophylaxis offers superior risk stratification for cytomegalovirus reactivation after liver transplantation Siddharth Sood, Craig Haifer, Lijia Yu, Liver Transplantation TransplantationHepatologySolid Organ TransplantationImmunologyTransplantation Medicine	2015	24
A novel immune function biomarker identifies patients at risk of clinical events early following liver transplantation Siddharth Sood, Craig Haifer, Lijia Yu, Liver Transplantation Clinical ImmunologySolid Organ TransplantationImmunodeficienciesImmunologyTransplantation Medicine	2017	23
Switching Australian patients with moderate to severe inflammatory bowel disease from originator to biosimilar infliximab: a multicentre, parallel cohort study Craig Haifer, Ashish Srinivasan, Yoon‐Kyo An, The Medical Journal of Australia	2020	20
Effects of Thiopurine Withdrawal on Vedolizumab-Treated Patients With Ulcerative Colitis: A Randomized Controlled Trial Aviv Pudipeddi, Sudarshan Paramsothy, Viraj C. Kariyawasam, Clinical Gastroenterology and Hepatology	2024	13
Early viral‐specific T‐cell testing predicts late cytomegalovirus reactivation following liver transplantation Siddharth Sood, Craig Haifer, Lijia Yu, Transplant Infectious Disease	2018	12
Entyvio lengthen dose-interval study: lengthening vedolizumab dose interval and the risk of clinical relapse in inflammatory bowel disease Webber Chan, Nicole Lynch, Peter A. Bampton, European Journal of Gastroenterology & Hepatology	2018	11

Page 1